Doing it for the Dead
This year, the future looks more hopeful for people at risk for and living with HIV than ever. Science shows that an AIDS-free generation is viable with the tools and knowledge in our hands and heads today.
Read Regan’s blog here: http://blogs.poz.com/regan/2012/12/my_top_12_things_to.html
An Exciting New Chapter!
Former POZ editor-in-chief Regan Hofmann shares news about her next step. She remains deeply committed to doing what she can to help usher in what science tells us is possible: an AIDS-free generation and, perhaps, even the end of the pandemic itself.
Oriol Gutierrez Named Editor-in-Chief of POZ
He becomes the first openly HIV-positive, gay Latino to helm the brand
Smart + Strong has named Oriol R. Gutierrez Jr. to editor-in-chief of POZ magazine and POZ.com, the leading HIV/AIDS resources in the United States. He had been deputy editor since 2008. He succeeds Regan Hofmann, who after nearly seven years as editor-in-chief, has started a new career as a consultant focused on strategy, communications and change in the field of global health.
During the XIX International AIDS Conference (AIDS 2012), Regan Hofmann, editor-in-chief of POZ, talked about activism with David France, director of How to Survive a Plague, which opens nationwide Friday, Sept. 21.
POZ TV: Moderated by Regan Hofmann, this roundtable discussion on the crisis in access to HIV care included Vignetta Charles, Laurie Dill, Cynthia Gomez, Kathie Hiers, David Holtgrave and David Munar.
Good Will Hunting
My last blog, "Not Drinking the PrEP Kool-AIDS" elicited a lot of response. I’ve read your comments and followed conversations on list serves with great interest and enjoyed talking with many of you about how PrEP (pre-exposure prophylaxis) might best be used to prevent new HIV infections and how its application should fit into the overall mix of tools we will wield to end AIDS.
Thank you for the depth, breadth and passion of your responses. Given the wide-range of your opinions, I hope we can continue the public dialogue to determine the optimal strategy for stopping the pandemic.
So much new scientific data have emerged in the last year—from the CAPRISA 004 results (a study of vaginal microbicides) to the findings of HPTN 052 (noting the impact of treatment as prevention in people with HIV) to the results of multiple PrEP studies (indicating that treatment can serve as prevention in people without the virus when used as a pre-exposure prophylaxis) to advancements in cure research. But the science is only half the battle. Click here for more.